TreeFrog Therapeutics is a French-based biotech aiming to unlock access to #iPS #StemCell derived #CellTherapies for millions of patients. #CellTherapyForAll" title="" class="btn" data-container="body" data-html="true" data-id="61000" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="TreeFrog Therapeutics"> 913 21,599
Global tags
Activities
Technologies
Entity types
Location
30 Av. Gustave Eiffel Bat A, 33600 Pessac, France
Pessac
France
Employees
Scale: 51-200
Estimated: 179
SIREN
343619102Engaged catalyst
51Added in Motherbase
5 years, 7 months agoCell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivation
Cell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | MOVE: Mobility Re-imagined | Other 14 Nov 2024 | | |
![]() Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 12 Apr 2025 | | |
![]() | Réseau SATT | Other 8 Oct 2024 | | |
![]() Apec Grand Est Human ressources, Human Resources Services | Apec Grand Est Human ressources, Human Resources Services | Other 4 Oct 2024 | | |
![]() Start Industrie Non-profit Organizations | Start Industrie Non-profit Organizations | Other 22 May 2024 | | |
![]() SAYENS Research, Startup accelerator & VC, Research Services | SAYENS Research, Startup accelerator & VC, Research Services | Other 11 May 2024 | | |
![]() Ministry of Economy Government Administration | Ministry of Economy Government Administration | Other 12 Feb 2024 | | |
![]() | SATT Aquitaine Science Transfert | Other 8 Oct 2024 | | |
![]() Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 14 Dec 2023 | | |
![]() ALPHA-RLH Research, Public business cluster, French Cluster, Research Services | ALPHA-RLH Research, Public business cluster, French Cluster, Research Services | Other 4 Dec 2023 | |
Technology | Entities | |
---|---|---|
Synthetic Biology | Plasticell Limited StemTek Therapeutics FUJIFILM Cellular Dynamics, Inc Scaled Biolabs Inc. SQZ Biotechnologies CellProthera SAS Cellforcure | View all |
Next week, two of our talented scientists Michèle DAI and Anne Mouré will be attending the TermisEU2025 in Freiburg for an exciting congress theme 'Shaping the future by connecting scientific diversity in tissue engineering and regenerative medicine'.
If you want to learn more about TreeFrog Therapeutics in this field, reach out to Michele and Anne!
#MicrotissueRules #CellTherapyForAll
Another week of travelling Froggies comes to a close with lots of learnings and interactions at #BPIEurope by Cyril ROLS and Loanne Milvoy and a late-breaking poster presented by Peter Andersen at #ASGCT2025!
Rest well Froggies!
#CellTherapyForAll
It’s time for our IMAGE OF THE MONTH from our fantastic Imaging team!
Blue skies are starting to arrive, so the team focused in on this beauty!
What do you see?
👍 James Webb Space Telescope's view of a supernova remnants
💡 Multicellular aggregate projecting neurites along a coverslip and into an artifical extracellular matrix, multiphoton microscopy, 3D-shaded projection. Size, approx 400 μm.
🩷 BaBa Blue Sheep: A microscopic look at a rare blue sheep hair before spinning
Or... describe what you see in the comments section!!
Image (c) Nadège Pujol/ Basile Gurchenkov
#CellTherapyForAll #ImagingBeauty
It’s #ASGCT2025 and we chose this congress to be the first company to publicly present a clinical-ready delivery strategy for 3D microtissues in cell therapy!
It took 4 years of development with teams right across TreeFrog and we are so proud of all the work they achieved!
The poster was chosen as part of the late-breaking session and Peter Andersen, our Head of R&D will be there to respond to any questions.
Date: May 15, 2025
Time: 5:30 PM – 7:00 PM
Venue: On-site Poster Hall
Title: Development of a Delivery Strategy for Neural Microtissues in Parkinson’s Disease Cell Therapy (#2039)
Check out the press release here
https://lnkd.in/e76Wjkvj
Thanks to all the authors, led by Nicolas Prudon, PhD - Anais MACHADO-HITAU Andrea Sovera Inês Neves Thibault Dufourd Guillaume Dabée Jérôme Hardoüin Caleb Anderson Marlène Martins William Tilmont Lucía Cordero Espinoza Blanche Tamarit Marie Lacaze Jens Schröder, MD PhD Kévin Alessandri Erwan Bezard Emilie Faggiani Maxime Feyeux
FR Version Below
Recently, Solenn Guilbert from our analytical development team presented to 250 students and attendees at the Neurocentre Magendie in Bordeaux. The objective was to showcase TreeFrog Therapeutics journey from an academia start-up to an R&D Biotech and highlight the opportunities for a wide variety of profiles needed within the company - from analytical engineers, stem cell biologists, bioproduction engineers and biophysicists to name just a few talents needed to drive the company forward to success.
Thanks for representing us Solenn!
FR version
Récemment, Solenn Guilbert de notre équipe de développement analytique a fait une présentation devant 250 étudiants et participants au Neurocentre Magendie à Bordeaux. L'objectif était de présenter le parcours de TreeFrog Therapeutics, qui est passé d'une start-up académique à une biotech de recherche et développement, et de souligner les opportunités pour une grande variété de profils nécessaires au sein de l'entreprise - ingénieurs analytiques, biologistes des cellules souches, ingénieurs en bioproduction et biophysiciens, pour ne citer que quelques-uns des talents nécessaires pour mener l'entreprise vers le succès.
Merci Solenn!